期刊文献+

超声引导下颈淋巴结穿刺联合血清TSH、SIL-2R水平检测与甲状腺癌患者颈部淋巴结转移及疾病严重程度的关系 被引量:36

Relationship between ultrasound-guided cervical lymph node puncture combined with serum TSH and SIL-2R levels in cervical lymph node metastasis and disease severity in patients with thyroid cancer
下载PDF
导出
摘要 目的探讨超声引导下颈淋巴结穿刺联合血清促甲状腺激素(thyrotropin,TSH)、可溶性白细胞介素2受体(soluble interleukin-2 receptor,SIL-2R)水平检测与甲状腺癌患者颈部淋巴结转移及疾病严重程度的关系。方法选择甲状腺癌患者120例,根据手术后病理结果分为Ⅰ/Ⅱ期组和Ⅲ/Ⅳ期组以及无转移组和转移组。所有患者均行超声引导下颈淋巴结穿刺检查,并检测血清TSH、SIL-2R水平。结果超声引导下颈淋巴结穿刺检测出106例淋巴结转移,准确率为85.00%(102/120)。超声引导下颈淋巴结穿刺对于Ⅱ期、Ⅲ期、Ⅳ期的淋巴结转移检测的准确率明显高于对于Ⅰ期甲状腺癌淋巴结转移的准确率(P<0.01)。Ⅲ/Ⅳ期组血清TSH和SIL-2R水平明显高于Ⅰ/Ⅱ期组(P<0.01)。甲状腺癌患者血清TSH和SIL-2R水平与病理分期呈正相关(P<0.01)。转移组血清TSH和SIL-2R水平明显高于无转移组(P<0.01)。对于甲状腺癌颈部淋巴结转移,超声穿刺、TSH、SIL-2R平行联合检测的准确度、敏感度、阴性预测值明显高于单项联合检测。结论Ⅲ/Ⅳ期或合并颈部淋巴结转移的甲状腺癌患者具有更高的血清TSH、SIL-2R水平,并且超声引导下颈淋巴结穿刺与血清TSH、SIL-2R联合检测可提高诊断的准确度和敏感度。 Objective To explore the relationship between ultrasound-guided cervical lymph node puncture combined with thyrotropin(TSH)and oluble interleukin-2 receptor(SIL-2R)and cervical lymph node metastasis and disease severity in patients with thyroid cancer.Methods One hundred and twenty patients with thyroid cancer were selected and divided into stageⅠ/Ⅱgroup and stageⅢ/Ⅳgroup,non-metastatic group and metastatic group according to the postoperative pathological results.All patients underwent ultrasound-guided cervical lymph node aspiration and their serum TSH and SIL-2R levels were measured.Results Ultrasound-guided cervical lymph node aspiration detected 106 lymph node metastases with an accuracy rate of 85.00%(102/120).The accuracy of ultrasound-guided cervical lymph node aspiration for stageⅡ,Ⅲ,andⅣlymph node metastasis was significantly higher than that for stage thyroid cancer lymph node metastasis(P<0.01).The levels of serum TSH and SIL-2R in stageⅢ/Ⅳgroup were significantly higher than those in stageⅠ/Ⅱgroup(P<0.01).Serum TSH and SIL-2R levels were positively correlated with pathological stage in patients with thyroid cancer(P<0.01).Serum TSH and SIL-2R levels in the metastatic group were significantly higher than those in the non-metastatic group(P<0.01).For cervical lymph node metastasis of thyroid cancer,the accuracy,sensitivity,and negative predictive value of the combined ultrasound puncture,TSH,and SIL-2R parallel tests were significantly higher than those of the single test.Conclusion Patients with stageⅢ/Ⅳor thyroid cancer with cervical lymph node metastasis have higher serum TSH and SIL-2R levels.Ultrasound-guided cervical lymph node aspiration combined with serum TSH and SIL-2R detection can improve the accuracy and sensitivity of diagnosis.
作者 王刚 谢丽娟 张明菊 WANG Gang;XIE Li-juan;ZHANG Ming-ju(Department of Otolaryngology and Head and Neck Surgery, Armed Police Sichuan Provincial General Hospital, Sichuan Province, Leshan 614000, China;Department of Special Clinic,Armed Police Sichuan Provincial General Hospital, Sichuan Province, Leshan 614000, China)
出处 《河北医科大学学报》 CAS 2020年第4期436-439,共4页 Journal of Hebei Medical University
关键词 甲状腺肿瘤 穿刺术 促甲状腺素 可溶性白细胞介素2受体 thyroid neoplasms punctures thyrotropin soluble interleukin-2 receptor
  • 相关文献

参考文献14

二级参考文献89

  • 1SKOURA E. Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging[J].Int J Endocrinol Metab,2013,11(4) :e8156.
  • 2BHATIA KS,RASALKAR DP,I.EE YP,et al.Cystic change in thyroid nodules: a confounding factor for real-time qualitative thyroid ultrasound elastography[J].Clin Radiol, 2011,66(9) :799-807.
  • 3Sawicka-Gutaj N, Klimowicz A, Sowinski J, et al. Pyramidal lobe de- creases endogenous TSH stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer[ J ]. Ann Dendocrinol (Paris) ,2014,75 ( 3 ) : 141-147.
  • 4Papaleontiou M, Haymart MR. New insights in risk stratification of dif- ferentiated thyroid cancer[ J]. Curr Opin Onco1,2014,26 ( 1 ) : 1-7.
  • 5McLeod DS. Thyrotmpin in the development and management of differ- entiated thyroid cancer[ J]. Endocrinol Metab Clin North Am,2014, 43(2) :367-383.
  • 6Kim H J, Lee JI, Kim NK, et al. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis [ J ]. World J Surg,2013,37 ( 12 ) : 2845-2852.
  • 7Kim HK, Yoon JH, Kim S J, et al. Higher TSH level is a risk factor for differentiated thyroid cancer [ J ]. Clin Endocrinol (Oxf) , 2013,78 ( 3 ) :472-477.
  • 8Pitoia F, Marlowe RJ, Abelleira E, et al. Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone with- drawal in patients with high-risk differentiated thyroid cancer [ J ]. J Thyroid Res ,2012,2012:481568.
  • 9Malandrino P, Latina A, Marescalco S, et al. Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin [ J ]. J Clin Endocrinol Metab, 2011,96 ( 6 ) : 1703-1709.
  • 10Middendorp M, Grunwald F. Update on recent developments in the therapy of differentiated thyroid cancer [ J ]. Semin Nucl Med, 2010, 40(2) :145-152.

共引文献212

同被引文献348

引证文献36

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部